A detailed history of Dimensional Fund Advisors LP transactions in Generation Bio Co. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 485,396 shares of GBIO stock, worth $1.18 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
485,396
Previous 504,251 3.74%
Holding current value
$1.18 Million
Previous $2.05 Million 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$2.64 - $4.35 $49,777 - $82,019
-18,855 Reduced 3.74%
485,396 $1.37 Million
Q1 2024

May 10, 2024

SELL
$1.73 - $4.07 $309,408 - $727,915
-178,849 Reduced 26.18%
504,251 $2.05 Million
Q4 2023

Feb 07, 2024

SELL
$0.91 - $3.35 $71,270 - $262,368
-78,319 Reduced 10.29%
683,100 $1.13 Million
Q3 2023

Nov 09, 2023

BUY
$3.65 - $6.9 $426,754 - $806,741
116,919 Added 18.14%
761,419 $2.89 Million
Q2 2023

Aug 09, 2023

BUY
$3.5 - $5.67 $348,827 - $565,100
99,665 Added 18.29%
644,500 $3.54 Million
Q1 2023

May 12, 2023

BUY
$3.61 - $7.01 $333,473 - $647,548
92,375 Added 20.42%
544,835 $2.34 Million
Q4 2022

Feb 09, 2023

BUY
$3.66 - $6.77 $437,322 - $808,926
119,487 Added 35.88%
452,460 $1.78 Million
Q3 2022

Nov 10, 2022

BUY
$4.68 - $8.34 $958,613 - $1.71 Million
204,832 Added 159.85%
332,973 $1.77 Million
Q2 2022

Aug 12, 2022

BUY
$4.87 - $9.41 $16,582 - $32,041
3,405 Added 2.73%
128,141 $842,000
Q1 2022

May 13, 2022

SELL
$4.16 - $7.76 $30,750 - $57,361
-7,392 Reduced 5.59%
124,736 $915,000
Q4 2021

Feb 09, 2022

BUY
$5.99 - $24.97 $438,929 - $1.83 Million
73,277 Added 124.51%
132,128 $935,000
Q3 2021

Nov 12, 2021

BUY
$20.0 - $27.43 $1.18 Million - $1.61 Million
58,851 New
58,851 $1.48 Million

Others Institutions Holding GBIO

About Generation Bio Co.


  • Ticker GBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,011,200
  • Market Cap $143M
  • Description
  • Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...
More about GBIO
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.